March 6, 2024
“…Chewy (NYSE: CHWY). The stock currently trades at around $16 per share, but Wall Street analysts are quite upbeat on the stock, maintaining an average price target of $31.62. That implies a 97% upside potential. Recently, the company received updated buy… Continue Reading…
March 4, 2024
“While artificial intelligence giant Nvidia (NVDA) has electrified the stock market, shares of another tech player — software company Confluent (CFLT) — shot up by double digits this year. Now, as the company sees 325% profit growth in 2024, Confluent stock is rising as… Continue Reading…
March 1, 2024
“…Shares of Hims & Hers closed up 31% to $13.43 as of Tuesday afternoon. They’re now up more than 50% for the year after climbing 39% in 2023… Revenue jumped 47% to $246.6 million, topping the $246 million expected by… Continue Reading…
February 26, 2024
“Share prices of Nvidia (NASDAQ: NVDA) and CrowdStrike (NASDAQ: CRWD) soared more than 1,000% and 400%, respectively, over the last four years. Those monster gains make the companies stock-split candidates in 2024, but both are worthwhile investments whether or not those splits happen… Grand View Research… Continue Reading…
February 19, 2024
“… …” https://investorplace.com/2023/12/3-hidden-gem-penny-growth-stocks-with-1000-upside/
February 2, 2024
“…Investment research firm Fundstrat’s Tom Lee predicts that the S&P 500 index will jump as much as 30% this year from 2023 levels. The Nasdaq-100 index is also seeing forecasts of robust gains in 2024 following the impressive 54% jump it clocked in 2023.… Continue Reading…
January 12, 2024
“…Recent reports already show signs of strain. In the last year, credit card debt spiked to a record high, surpassing $1.08 trillion, according to the latest quarterly report from the Federal Reserve Bank of New York. Now, more cardholders are carrying debt from month to… Continue Reading…
January 8, 2024
“…Nonfarm payrolls increased by 216,000 jobs last month, the Labor Department’s Bureau of Labor Statistics said in its closely watched employment report on Friday. Data for November was revised lower to show payrolls rising 173,000 instead of 199,000 as previously… Continue Reading…
December 11, 2023
“Johnson & Johnson on Tuesday forecast revenue growth of 5% to 6% for the next year, as it banks on strong demand for cancer treatments Darzalex and Carvykti and resilient sales of blockbuster drug Stelara… The company expects full-year adjusted operational… Continue Reading…
Recent Comments